Inspire Medical Systems Net Income
| INSP Stock | USD 59.79 0.14 0.23% |
As of the 13th of February 2026, Inspire Medical retains the Market Risk Adjusted Performance of (0.14), standard deviation of 6.13, and Risk Adjusted Performance of (0.03). Inspire Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Inspire Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.5641 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 61.5 M | 64.6 M | |
| Net Loss | -40.4 M | -42.4 M | |
| Net Income | 61.5 M | 64.6 M | |
| Net Income Per Share | 4.95 | 5.20 | |
| Net Income Per E B T | 2.21 | 2.32 |
Inspire | Net Income | Build AI portfolio with Inspire Stock |
Evaluating Inspire Medical's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Inspire Medical Systems's fundamental strength.
Latest Inspire Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Inspire Medical Systems over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Inspire Medical Systems financial statement analysis. It represents the amount of money remaining after all of Inspire Medical Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Inspire Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inspire Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 53.51 M | 10 Years Trend |
|
Net Income |
| Timeline |
Inspire Net Income Regression Statistics
| Arithmetic Mean | (12,044,384) | |
| Geometric Mean | 29,684,703 | |
| Coefficient Of Variation | (299.52) | |
| Mean Deviation | 25,387,014 | |
| Median | (21,337,000) | |
| Standard Deviation | 36,075,397 | |
| Sample Variance | 1301.4T | |
| Range | 121.8M | |
| R-Value | 0.50 | |
| Mean Square Error | 1035.9T | |
| R-Squared | 0.25 | |
| Significance | 0.04 | |
| Slope | 3,598,829 | |
| Total Sum of Squares | 20822.9T |
Inspire Net Income History
Other Fundumenentals of Inspire Medical Systems
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Inspire Medical Net Income component correlations
Inspire Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Inspire Medical is extremely important. It helps to project a fair market value of Inspire Stock properly, considering its historical fundamentals such as Net Income. Since Inspire Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Inspire Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Inspire Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Can Health Care Technology industry sustain growth momentum? Does Inspire have expansion opportunities? Factors like these will boost the valuation of Inspire Medical. Market participants price Inspire higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Inspire Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.44) | Earnings Share 4.89 | Revenue Per Share | Quarterly Revenue Growth 0.105 | Return On Assets |
Investors evaluate Inspire Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Inspire Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Inspire Medical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Inspire Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Inspire Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Inspire Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Inspire Medical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Inspire Medical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Inspire Medical Systems or generate 0.0% return on investment in Inspire Medical over 90 days. Inspire Medical is related to or competes with Sophia Genetics, Definitive Healthcare, OPTIMIZERx Corp, Alto Neuroscience, Cellectis, Kindly MD, and Frequency Therapeutics. Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimal... More
Inspire Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Inspire Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Inspire Medical Systems upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 49.96 | |||
| Value At Risk | (8.74) | |||
| Potential Upside | 6.01 |
Inspire Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inspire Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Inspire Medical's standard deviation. In reality, there are many statistical measures that can use Inspire Medical historical prices to predict the future Inspire Medical's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.15) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Inspire Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Inspire Medical February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.14) | |||
| Mean Deviation | 3.64 | |||
| Coefficient Of Variation | (2,065) | |||
| Standard Deviation | 6.13 | |||
| Variance | 37.6 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.15) | |||
| Maximum Drawdown | 49.96 | |||
| Value At Risk | (8.74) | |||
| Potential Upside | 6.01 | |||
| Skewness | 1.26 | |||
| Kurtosis | 10.63 |
Inspire Medical Systems Backtested Returns
Inspire Medical Systems holds Efficiency (Sharpe) Ratio of -0.0542, which attests that the entity had a -0.0542 % return per unit of risk over the last 3 months. Inspire Medical Systems exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inspire Medical's Risk Adjusted Performance of (0.03), market risk adjusted performance of (0.14), and Standard Deviation of 6.13 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.06, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inspire Medical will likely underperform. At this point, Inspire Medical Systems has a negative expected return of -0.34%. Please make sure to check out Inspire Medical's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Inspire Medical Systems performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.35 |
Below average predictability
Inspire Medical Systems has below average predictability. Overlapping area represents the amount of predictability between Inspire Medical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Inspire Medical Systems price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current Inspire Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 132.82 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Inspire Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Inspire Medical Systems reported net income of 53.51 M. This is 84.32% lower than that of the Health Care Technology sector and 77.53% lower than that of the Health Care industry. The net income for all United States stocks is 90.63% higher than that of the company.
Inspire Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inspire Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inspire Medical could also be used in its relative valuation, which is a method of valuing Inspire Medical by comparing valuation metrics of similar companies.Inspire Medical is currently under evaluation in net income category among its peers.
Inspire Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Inspire Medical from analyzing Inspire Medical's financial statements. These drivers represent accounts that assess Inspire Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Inspire Medical's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 6.3B | 7.1B | 6.0B | 2.7B | 2.4B | 2.4B | |
| Enterprise Value | 4.7B | 6.1B | 6.6B | 5.8B | 5.2B | 2.6B |
Inspire Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Inspire Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Inspire Medical's managers, analysts, and investors.Environmental | Governance | Social |
Inspire Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Inspire Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Inspire Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Inspire Medical's value.| Shares | Braidwell Lp | 2025-06-30 | 522.4 K | Geode Capital Management, Llc | 2025-06-30 | 512.8 K | Timessquare Capital Management, Llc | 2025-06-30 | 499.2 K | Macquarie Group Ltd | 2025-06-30 | 495.6 K | Bamco Inc | 2025-06-30 | 491.8 K | Ubs Group Ag | 2025-06-30 | 430.7 K | Champlain Investment Partners, Llc | 2025-06-30 | 412.1 K | Jpmorgan Chase & Co | 2025-06-30 | 384 K | Man Group Plc | 2025-06-30 | 380.3 K | Blackrock Inc | 2025-06-30 | 3.9 M | Vanguard Group Inc | 2025-06-30 | 3.2 M |
Inspire Fundamentals
| Return On Equity | 0.0654 | ||||
| Return On Asset | 0.0286 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 1.43 B | ||||
| Shares Outstanding | 28.58 M | ||||
| Shares Owned By Insiders | 1.10 % | ||||
| Shares Owned By Institutions | 98.90 % | ||||
| Number Of Shares Shorted | 3.87 M | ||||
| Price To Earning | 15.29 X | ||||
| Price To Book | 2.18 X | ||||
| Price To Sales | 1.96 X | ||||
| Revenue | 802.8 M | ||||
| Gross Profit | 749.48 M | ||||
| EBITDA | 65.03 M | ||||
| Net Income | 53.51 M | ||||
| Cash And Equivalents | 196.32 M | ||||
| Cash Per Share | 7.10 X | ||||
| Total Debt | 31.79 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 5.62 X | ||||
| Book Value Per Share | 22.94 X | ||||
| Cash Flow From Operations | 130.25 M | ||||
| Short Ratio | 3.11 X | ||||
| Earnings Per Share | 4.89 X | ||||
| Price To Earnings To Growth | (2.57) X | ||||
| Target Price | 90.8 | ||||
| Number Of Employees | 1.25 K | ||||
| Beta | 0.72 | ||||
| Market Capitalization | 1.73 B | ||||
| Total Asset | 808.38 M | ||||
| Retained Earnings | (291.91 M) | ||||
| Working Capital | 542.3 M | ||||
| Current Asset | 167.55 M | ||||
| Current Liabilities | 64.84 M | ||||
| Net Asset | 808.38 M |
About Inspire Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inspire Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inspire Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inspire Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Inspire Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Inspire Stock
Moving against Inspire Stock
| 0.64 | APETF | Alpha Esports Tech | PairCorr |
| 0.62 | AROC | Archrock Symbol Change | PairCorr |
| 0.61 | BIMT | Bitmis Corp | PairCorr |
| 0.6 | ALMDT | Mediantechn | PairCorr |
| 0.55 | CHS | Comprehensive Healthcare | PairCorr |
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.